Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2026-01-10 @ 4:47 AM
Study NCT ID:
NCT00982150
Status:
TERMINATED
Last Update Posted:
2013-08-26
First Post:
2009-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.